Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis

Objectives The aims were to compare the performance of cardiovascular risk calculators, Framingham Risk Score (FRS) and QRISK2, in RA and matched non-RA patients and to evaluate whether their performance could be enhanced by the addition of CRP. Methods We conducted a retrospective analysis, using a clinical practice data set linked to Hospital Episode Statistics (HES) data from the UK. Patients presenting with at least one RA diagnosis code and no prior cardiovascular events were matched to non-RA patients using disease risk scores. The overall performance of the FRS and QRISK2 was compared between cohorts, and assessed with and without CRP in the RA cohort using C-Index, Akaike Information Criterion (AIC) and the net reclassification index (NRI). Results Four thousand seven hundred and eighty RA patients met the inclusion criteria and were followed for a mean of 3.8 years. The C-Index for the FRS in the non-RA and RA cohort was 0.783 and 0.754 (P < 0.001) and that of the QRISK2 was 0.770 and 0.744 (P < 0.001), respectively. Log[CRP] was positively associated with cardiovascular events, but improvements in the FRS and QRISK2 C-Indices as a result of inclusion of CRP were small, from 0.764 to 0.767 (P = 0.026) for FRS and from 0.764 to 0.765 (P = 0.250) for QRISK2. The NRI was 3.2% (95% CI: -2.8, 5.7%) for FRS and -2.0% (95% CI: -5.8, 4.5%) for QRISK2. Conclusion The C-Index for the FRS and QRISK2 was significantly better in the non-RA compared with RA patients. The addition of CRP in both equations was not associated with a significant improvement in reclassification based on NRI.

[1]  J. Hippisley-Cox,et al.  Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study , 2007, Heart.

[2]  D. Symmons,et al.  EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis , 2009, Annals of the rheumatic diseases.

[3]  M. Hochberg,et al.  Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity , 2010, Annals of the rheumatic diseases.

[4]  L. Trinquart,et al.  High risk of clinical cardiovascular events in rheumatoid arthritis: Levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. , 2010, Archives of cardiovascular diseases.

[5]  C. Turesson,et al.  Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study , 2004, Annals of the rheumatic diseases.

[6]  G L Freeman,et al.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.

[7]  E. Arnesen,et al.  Total Mortality is Increased in Rheumatoid Arthritis. A 17-Year Prospective Study , 2001, Clinical Rheumatology.

[8]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[9]  S. Gabriel,et al.  Risk factors for cardiovascular disease in rheumatoid arthritis , 2012, Current opinion in rheumatology.

[10]  Peter C Austin,et al.  A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study , 2007, Statistics in medicine.

[11]  L. Smeeth,et al.  How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in the general practice research database? , 2008, Arthritis and rheumatism.

[12]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[13]  M. Kaplan.  Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. , 2010, Rheumatic diseases clinics of North America.

[14]  C. Kallenberg,et al.  Risk factors and early detection of atherosclerosis in rheumatoid arthritis , 2010, European journal of clinical investigation.

[15]  J. Avorn,et al.  Patterns of cardiovascular risk in rheumatoid arthritis , 2006, Annals of the rheumatic diseases.

[16]  P. Raggi,et al.  Brief Report: The Ability of the 2013 American College of Cardiology/American Heart Association Cardiovascular Risk Score to Identify Rheumatoid Arthritis Patients With High Coronary Artery Calcification Scores , 2015, Arthritis & rheumatology.

[17]  L. Trinquart,et al.  Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. , 2009, Rheumatology.

[18]  P. V. van Riel,et al.  The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients , 2014, Annals of the rheumatic diseases.

[19]  D. Margolis,et al.  Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study , 2014, Annals of the rheumatic diseases.

[20]  G. Kitas,et al.  Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms , 2015, Annals of the rheumatic diseases.

[21]  I. McInnes,et al.  Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. , 2003, Circulation.

[22]  M. Abrahamowicz,et al.  Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. , 2013, Rheumatology.

[23]  R. Jackson.  Guidelines on preventing cardiovascular disease in clinical practice , 2000, BMJ : British Medical Journal.

[24]  Mohsen Sadatsafavi,et al.  Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. , 2008, Arthritis and rheumatism.

[25]  T. Therneau,et al.  Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. , 2012, The American journal of cardiology.

[26]  M. Pencina,et al.  Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.

[27]  Jennifer G. Robinson,et al.  Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health Initiative , 2012, Circulation.

[28]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[29]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[30]  D. Solomon,et al.  SAT0069 Performance of the Framingham Cardiovascular Risk Prediction Model with and without C-Reactive Protein or Erythrocyte Sedimentation Rate in RA: Analysis of US Electronic Medical Records Database , 2014 .

[31]  M. A. van de Laar,et al.  Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature , 2014, BMC Musculoskeletal Disorders.

[32]  G. Kitas,et al.  Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis , 2014, Annals of the rheumatic diseases.

[33]  JoAnn E. Manson,et al.  Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis , 2003, Circulation.

[34]  N. Goodson,et al.  Rheumatoid arthritis in women: still associated with an increased mortality , 2002, Annals of the rheumatic diseases.

[35]  C Michael Stein,et al.  COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease , 2002, The Lancet.

[36]  J. Kremer,et al.  Derivation and Internal Validation of an Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis: A Consortium of Rheumatology Researchers of North America Registry Study , 2015, Arthritis & rheumatology.

[37]  S. Gabriel,et al.  Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. , 2007, The Journal of rheumatology.